4.7 Article

Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia

Journal

GASTROINTESTINAL ENDOSCOPY
Volume 87, Issue 1, Pages 95-101

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.gie.2017.04.036

Keywords

-

Funding

  1. Endostim
  2. Medical Measurement Systems
  3. Danone
  4. MMS
  5. Astellas
  6. AstraZeneca
  7. Almirall
  8. Ironwood
  9. Medtronic
  10. Sandhill
  11. Fujifilm
  12. Olympus
  13. Cook

Ask authors/readers for more resources

Background and Aims: Per-oral endoscopic myotomy (POEM) has been rapidly gaining ground as a treatment for achalasia. Although POEM is a safe and effective treatment, a subset of patients has persistent or recurrent symptoms after POEM. This study aimed to examine the efficacy of different retreatments after failed POEM. Methods: POEM was performed on 441 patients with achalasia at 3 tertiary-care hospitals between 2010 and 2015. A review of prospectively collected data was conducted. All patients with achalasia with significant persistent or recurrent symptoms within 3 years after POEM, defined as an Eckardt symptom score >3, were included. Results: Forty-three of 441 patients (9.8%) had persistent or recurrent symptoms after POEM, of which 34 (8%) received 1 or more retreatments. Retreatment with laparoscopic Heller myotomy and retreatment with POEM showed a modest efficacy of 45% and 63%, respectively, whereas pneumatic dilatation showed a poor efficacy of only 0% to 20%, depending on the size of the balloon. Male patients were more likely to have retreatment failure than female patients (P = .038). Conclusions: In patients with achalasia with persistent or recurrent symptoms after failed POEM, retreatment with laparoscopic Heller myotomy or retreatment with POEM has a higher efficacy than retreatment with pneumatic dilatations. Failure of retreatment occurred more often in male patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available